Company Filing History:
2 out of 444 
2 out of 2,893 
1 out of 2,968 
Years Active: 2025
Title: The Innovative Contributions of Nir Hacohen
Introduction
Nir Hacohen is a prominent inventor based in Boston, MA (US). He has made significant contributions to the field of immunology and cancer research. With a total of 2 patents, Hacohen's work focuses on developing innovative solutions for treating diseases.
Latest Patents
Hacohen's latest patents include groundbreaking inventions. The first patent is titled "Immunogenic compositions and use thereof." This invention comprises immunogenic compositions that include one or more polypeptides capable of binding to Major Histocompatibility Complex (MHC) class I, derived from proteins of SARS-COV-2. It also provides methods for treating and preventing diseases using these immunogenic compositions. The second patent is "Methods for predicting outcomes and treating colorectal cancer using a cell atlas." This invention presents a colorectal cell atlas that aids in predicting cancer patient outcomes and identifying therapeutic targets. It can predict responses to immunotherapy, particularly checkpoint blockade therapy and adoptive cell transfer.
Career Highlights
Throughout his career, Hacohen has worked with esteemed organizations. He has been associated with The Broad Institute, Inc. and The General Hospital Corporation. His work in these institutions has contributed to advancements in medical research and innovation.
Collaborations
Hacohen has collaborated with notable colleagues in his field, including Pardis Sabeti and Shira Weingarten-Gabbay. These collaborations have further enhanced his research and contributions to science.
Conclusion
Nir Hacohen's innovative work in immunology and cancer research has led to significant advancements in the field. His patents reflect his commitment to developing effective treatments and predictive methods for diseases. Hacohen's contributions continue to impact the scientific community and improve patient outcomes.